CHERENKOV IMAGING SYSTEMS AND METHODS TO MONITOR BEAM PROFILES AND RADIATION DOSE WHILE AVOIDING INTERFERENCE FROM ROOM LIGHTING
    2.
    发明申请
    CHERENKOV IMAGING SYSTEMS AND METHODS TO MONITOR BEAM PROFILES AND RADIATION DOSE WHILE AVOIDING INTERFERENCE FROM ROOM LIGHTING 审中-公开
    CHERENKOV成像系统和方法来监控光束照明和辐射剂量,避免室内干扰

    公开(公告)号:US20160263402A1

    公开(公告)日:2016-09-15

    申请号:US15160576

    申请日:2016-05-20

    Abstract: A monitor for pulsed high energy radiation therapy using a radiation beam passing through a treatment zone, the radiation of 0.2 MEV or greater; has a camera for imaging Cherenkov light from the treatment zone; apparatus for preventing interference by room lighting, the camera synchronized to pulses of the radiation beam; and an image processor adapted to determine extent of the beam area on the patient skin from the images. Additionally an image processor determines cumulative skin dose in the treatment zone from the images. In embodiments, the processor uses a three-dimensional model of a subject to determine mapping of image intensity in images of Cherenkov light to radiation intensity in skin, applies the mapping to images of Cherenkov light to verify skin dose delivered, and accumulates skin dose by summing the maps of skin dose.

    Abstract translation: 使用穿过治疗区域的辐射束进行脉冲高能量放射治疗的监测仪,0.2MEV或更大的辐射; 有一个摄像头,用于对来自治疗区的切伦科夫灯进行成像; 用于防止室内照明干扰的装置,照相机与辐射束的脉冲同步; 以及图像处理器,适于从图像确定患者皮肤上的束区域的范围。 此外,图像处理器从图像确定处理区域中的累积皮肤剂量。 在实施例中,处理器使用对象的三维模型来确定切伦科夫光图像中的图像强度与皮肤中的辐射强度的映射,将切布伦科夫光图像应用于图像以验证皮肤剂量递送,并且通过 总结皮肤剂量图。

    MEDICAL IMAGING TECHNIQUE USING X-RAY TO NEAR-INFRARED DOWNCONVERTING NANOPOWDER

    公开(公告)号:US20210353778A1

    公开(公告)日:2021-11-18

    申请号:US17322577

    申请日:2021-05-17

    Abstract: A phosphor excitable by X-ray and blue-light emits light in the near-infrared (NIR-II, 1000-1700 nanometers) forms nanoparticles less than 200 nanometers diameter. The nanoparticles are tagged by coating with silica, then conjugating with polyethylene glycol (PEG) and tissue-selective compounds such as antibodies, nucleic acid chains, and other ligands. In embodiments, we administer the tagged nanoparticles to a subject, then localize the nanoparticles, and thus antigen-bearing tissues, by irradiating the subject with X-ray or other radiation beams while imaging near infrared light emitted from the subject. The nanoparticles are made by mixing 1-50 micron calcium oxide and germanium oxide powders with dilute nitric acid, adding chromium (III) nitrate at a ratio to germanium between 0.001 and 0.1, adding tartaric acid solution with molar ratio to metal ions between 1-10, and adjusting pH to 0.1-4 with nitric acid, then later heating to form a sol, oven drying, and calcinating the sol.

Patent Agency Ranking